Bio‑Rad (BIO) Director Allison Schwartz Receives RSUs

What Happened

• Allison Schwartz, a director of Bio‑Rad Laboratories (BIO), received 719 restricted stock units (RSUs) that vested on 2026-09-04. The RSUs converted to Class A common shares in transactions on 2026-09-05 and 2026-09-06. A total of 116 shares were withheld to satisfy tax obligations, resulting in cash value withheld of $31,661 (82 shares) on 9/05 and $13,128 (34 shares) on 9/06, using $386.11 per share.

Key Details

• Transactions and amounts:
  • 2026-09-04: Grant/vesting of 719 RSUs (award, $0 reported as grant value).
  • 2026-09-05: Conversion/exercise of 228 derivative units into shares (acquired) and 82 shares withheld for tax liability (disposed) at $386.11/share = $31,661.
  • 2026-09-06: Conversion/exercise of 92 derivative units into shares (acquired) and 34 shares withheld for tax liability (disposed) at $386.11/share = $13,128.
  • Total tax withholding: 116 shares; total withheld value ≈ $44,789.
• Footnotes: Each RSU represents the right to one Class A share. RSUs vest over four years (25% on the first anniversary, remaining units in equal quarterly installments), per the filing.
• Shares owned after the transactions: not specified in the supplied filing excerpt.
• Filing: Form 4 filed 2026-09-09, reporting vesting and conversion events dated 2026-09-04 through 2026-09-06.

Context

• These filings show an award (vesting) and conversion of RSUs to common stock, not an open‑market purchase or a voluntary sale for investment. The disposals reported (code F) are share withholdings to satisfy tax liabilities — a routine administrative step following vesting. Such withholdings are common and do not necessarily indicate a change in the insider’s view of the company.